Bayesian Capital Management, LP - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q4 2022$972,952
+28.5%
140,600
+17.6%
0.14%
-7.2%
Q3 2022$757,000
+63.5%
119,600
+1017.8%
0.15%
+26.4%
Q4 2020$463,000
+24.1%
10,700
+54.9%
0.12%
+33.0%
Q3 2020$373,000
-44.4%
6,909
+83.4%
0.09%
-33.6%
Q4 2017$671,0003,7670.14%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders